Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CXCR2--the receptor to hit?

Jörg Reutershan1

  • 1Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Hoppe-Seyler-Str. 3, 72076 Tübingen, Germany. joerg.reutershan@uni-tuebingen.de

Drug News & Perspectives
|February 15, 2007
PubMed
Summary

Excessive leukocyte recruitment drives inflammatory diseases. Blocking CXC chemokine receptor 2 (CXCR2) reduces this recruitment, tissue damage, and mortality, highlighting CXCR2 as a potential drug target.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Operating room scheduling: knowing and accepting your limits.

British journal of anaesthesia·2024
Same author

Occurrence and Severity of Venous Air Embolism During Neurosurgical Procedures: Semisitting Versus Supine Position.

World neurosurgery·2022
Same author

Sevoflurane Exerts Protective Effects in Murine Peritonitis-induced Sepsis via Hypoxia-inducible Factor 1α/Adenosine A2B Receptor Signaling.

Anesthesiology·2021
Same author

Fractalkine Is Linked to the Necrosome Pathway in Acute Pulmonary Inflammation.

Frontiers in medicine·2021
Same author

Fatal Clostridium perfringens Meningitis Following Caudal Anesthesia in an Infant: A Case Report.

A&A practice·2020
Same author

Staff time requirements for postoperative pain management: Comparison of sufentanil sublingual tablet system and intravenous patient-controlled analgesia.

Journal of opioid management·2020

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Leukocyte emigration is crucial for immunity but excessive recruitment causes inflammatory diseases.
  • Chemokines and their receptors, like CXC chemokine receptor 2 (CXCR2), mediate leukocyte trafficking.
  • CXCR2 plays a significant role in various acute and chronic inflammatory conditions.

Purpose of the Study:

  • To review the role of CXCR2 in inflammatory diseases.
  • To discuss the therapeutic potential of targeting CXCR2.

Main Methods:

  • Literature review of studies on CXCR2 in inflammation.
  • Analysis of data from preclinical models and clinical trials involving CXCR2 inhibitors.

Main Results:

  • Blockade of CXCR2 significantly reduces leukocyte recruitment in inflammatory models.
  • Inhibition of CXCR2 decreases tissue damage and mortality rates.
  • Selective CXCR2 inhibitors are currently in clinical trials.

Conclusions:

  • CXCR2 is a key mediator of leukocyte recruitment in inflammation.
  • Targeting CXCR2 presents a promising therapeutic strategy for inflammatory diseases.

Related Experiment Videos